According to Ladenburg Thalmann, Seracare Life Sciences SRLS and been the subject of an unsolicited $4.25 offer.
Ladenburg Thalmann said that on 6/23/11, an investor group disclosed an unsolicited bid to acquire SRLS for $4.25 per share in cash with a deadline of 5:00 PM EST 7/11/11 for SRLS to respond to its offer and until 7/29/11 to enter a definitive merger agreement. “Reiterating Neutral rating.”
Seracare Life Sciences closed on Friday at $3.90.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in